Your session is about to expire
← Back to Search
Tobacco Cessation Treatments for Tobacco Use (MESH Trial)
MESH Trial Summary
This trial will study whether a new treatment plan that includes personalized counseling, medications, and text messaging can help people quit smoking.
MESH Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMESH Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MESH Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are not currently using regular cigarettes or smokeless tobacco, but vaping is allowed.You smoke cigarettes, cigars, or use smokeless tobacco at least once a week.You smoke or use smokeless tobacco at least once a day.You are a patient of the Durham VA healthcare system.
- Group 1: MESH
- Group 2: Best Practice Telehealth Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there currently an opportunity for participants to join this scientific experiment?
"Affirmative. According to the information on clinicaltrials.gov, this trial is currently recruiting individuals for participation; it was first published online on May 2nd 2022 and updated most recently on May 5th 2022. The study seeks 30 participants from one medical location."
What is the highest possible number of participants in this research project?
"Affirmative. The information posted on clinicaltrials.gov reveals that this investigation is currently seeking participants, having first been advertised on May 2nd 2022 with an update made to the listing on May 5th 2022. 30 individuals are being recruited from a single site for enrolment in the trial."
What potential detriments may occur from utilizing Personalized Smoking Cessation Pharmacotherapy?
"Our experts at Power have scored Personalized Smoking cessation Pharmacotherapy a 3, as it is in its fourth phase of clinical trials and has thus been approved for use."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger